MetaVia Inc. – Transcripts

NASDAQ: MTVA
Share price (6/2/26): $2.71
Market cap (6/2/26): $14.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2019

Other Revised 07/25/19 NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc. - M&A Call 07/25/19

CY 2018

Other Revised 08/06/18 Gemphire Therapeutics Inc. - Special Call 08/06/18

Other Revised 06/28/18 Gemphire Therapeutics Inc. - Special Call 06/28/18

Earnings Revised 03/15/18 Gemphire Therapeutics Inc., Q4 2017 Earnings Call, Mar 15, 2018 03/15/18

Other Revised 01/31/18 Gemphire Therapeutics Inc. - Special Call 01/31/18

CY 2017

Other Revised 08/07/17 Gemphire Therapeutics Inc. - Special Call 08/07/17

Other Revised 06/28/17 Gemphire Therapeutics Inc. - Special Call 06/28/17